---
name: get_anticoagulant_chemical_properties
description: >
  Retrieves comprehensive chemical properties for specific drugs from PubChem using dynamic drug name lookup.
  Returns molecular formula, weight, SMILES, InChI, LogP, TPSA, and hydrogen bond donor/acceptor counts.
  Requires specific drug names (not drug classes). Defaults to anticoagulants (warfarin, rivaroxaban, apixaban).

  Note: PubChem API limitation - drug class searches (e.g., 'oral anticoagulants', 'SGLT2 inhibitors')
  are NOT supported. Use specific drug names only.
category: drug-discovery
mcp_servers:
  - pubchem_mcp
patterns:
  - dynamic_search
  - json_parsing
  - multi_compound_query
  - parameterized_skill
  - name_to_cid_lookup
data_scope:
  total_results: "User-specified (1-100+ specific drugs)"
  geographical: Global
  temporal: Current
created: 2025-11-22
last_updated: 2025-11-29
complexity: medium
execution_time: "~2 seconds per drug"
token_efficiency: 99%
parameterized: true
---
# get_anticoagulant_chemical_properties

**General-Purpose Drug Chemical Property Analyzer** (works for specific drug names)

## Sample Queries

Examples of user queries that would trigger this skill (all use **specific drug names**):

### Anticoagulants (Default)
1. `@agent-pharma-search-specialist Compare chemical properties of warfarin, rivaroxaban, and apixaban`
2. `@agent-pharma-search-specialist What are the LogP and TPSA values for warfarin, apixaban, and rivaroxaban?`

### GLP-1 Agonists
3. `@agent-pharma-search-specialist Compare semaglutide and liraglutide chemical properties`
4. `@agent-pharma-search-specialist What are the molecular weights of semaglutide, liraglutide, and tirzepatide?`

### Specific Drugs (Any Therapeutic Area)
5. `@agent-pharma-search-specialist Get chemical properties for aspirin`
6. `@agent-pharma-search-specialist Analyze drug-likeness of ibuprofen and naproxen`
7. `@agent-pharma-search-specialist Compare TPSA values for metformin, empagliflozin, and canagliflozin`
8. `@agent-pharma-search-specialist Show me molecular properties for atorvastatin and rosuvastatin`

**Note**: All queries must specify drug names. Drug class queries like "Get properties for oral anticoagulants" or "Show me SGLT2 inhibitors" are NOT supported due to PubChem API limitations.

## Purpose

**Universal drug chemical property analyzer** that retrieves physicochemical properties for specific drugs from PubChem. Simply provide specific drug names and get instant access to key molecular descriptors.

**Key Innovation**: **Parameterized + Dynamic CID Lookup**
- Accepts specific drug names as input (not hardcoded)
- Automatically finds PubChem CIDs via drug name search
- Works for small molecules, biologics, peptides, antibodies
- Defaults to anticoagulants if no drugs specified (backward compatible)

**Important Limitation**: PubChem `search_compounds` API does NOT support drug class searches. You must provide **specific drug names** (e.g., "warfarin", "aspirin"), not drug classes (e.g., "oral anticoagulants", "NSAIDs"). This is an API constraint, not a skill limitation.

This skill enables:

- **Drug-likeness assessment**: Lipinski's Rule of 5 evaluation for oral bioavailability
- **Bioavailability prediction**: LogP and TPSA indicators of membrane permeability
- **Structural comparison**: SMILES/InChI for computational modeling and similarity analysis
- **Formulation insights**: Hydrogen bonding characteristics for drug design
- **Competitive analysis**: Compare physicochemical properties across drug classes

Key data returned:
- **Molecular formula and weight**: Composition and size
- **Lipophilicity (XLogP)**: Membrane permeability predictor
- **Topological polar surface area (TPSA)**: Blood-brain barrier permeability
- **Hydrogen bonding**: Donor/acceptor counts for binding affinity
- **Structural identifiers**: SMILES and InChI for cheminformatics

## Usage

**Direct execution** (with drug names):
```bash
# Custom drugs
PYTHONPATH=.claude:$PYTHONPATH python3 .claude/skills/anticoagulant-chemical-properties/scripts/get_anticoagulant_chemical_properties.py semaglutide liraglutide

# Single drug
PYTHONPATH=.claude:$PYTHONPATH python3 .claude/skills/anticoagulant-chemical-properties/scripts/get_anticoagulant_chemical_properties.py aspirin

# Default (anticoagulants)
PYTHONPATH=.claude:$PYTHONPATH python3 .claude/skills/anticoagulant-chemical-properties/scripts/get_anticoagulant_chemical_properties.py
```

**Import and use**:
```python
from skills.anticoagulant_chemical_properties.scripts.get_anticoagulant_chemical_properties import get_anticoagulant_chemical_properties

# Custom drugs
result = get_anticoagulant_chemical_properties(['semaglutide', 'liraglutide'])

# Default anticoagulants
result = get_anticoagulant_chemical_properties()

print(f"Total compounds: {result['total_compounds']}")
for compound in result['data']:
    print(f"{compound['name']}: MW={compound['molecular_weight']}, LogP={compound['xlogp']}")
```

## Parameters

**drug_names** (Optional[List[str]]): List of **specific drug names** to analyze
- **Default**: `None` → Uses anticoagulants (warfarin, rivaroxaban, apixaban)
- **Examples**:
  - `['semaglutide', 'liraglutide']` → GLP-1 agonists
  - `['aspirin']` → Single drug
  - `['metformin', 'empagliflozin', 'canagliflozin']` → Diabetes drugs
  - Any specific drug names recognized by PubChem

**Important**: Use **specific drug names only**, NOT drug classes:
- ✅ `['warfarin', 'aspirin']` (specific names)
- ❌ `'oral anticoagulants'` (drug class - NOT supported by PubChem API)
- ❌ `'SGLT2 inhibitors'` (drug class - NOT supported)

**How it works**:
1. **Dynamic CID lookup**: Searches PubChem by drug name to find compound ID
2. **Property retrieval**: Fetches molecular descriptors using CID
3. **Structured output**: Returns standardized property dict for each drug

## Output Structure

Returns dict with:
```python
{
    'total_compounds': 3,
    'compounds_retrieved': ['Warfarin', 'Rivaroxaban', 'Apixaban'],
    'data': [
        {
            'name': 'Warfarin',
            'cid': 54678486,
            'molecular_formula': 'C19H16O4',
            'molecular_weight': '308.3',
            'canonical_smiles': 'CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O',
            'inchi': 'InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)...',
            'xlogp': 2.7,
            'tpsa': 63.6,
            'h_bond_donors': 1,
            'h_bond_acceptors': 4
        },
        # ... 2 more compounds
    ]
}
```

## Example Output

### Default Anticoagulants
```bash
$ python3 get_anticoagulant_chemical_properties.py

Warfarin (CID: 54678486)
  Formula: C19H16O4, MW: 308.3 g/mol
  XLogP: 2.7, TPSA: 63.6 Ų
  H-bond donors: 1, H-bond acceptors: 4

Rivaroxaban (CID: 9875401)
  Formula: C19H18ClN3O5S, MW: 435.9 g/mol
  XLogP: 2.5, TPSA: 116 Ų
  H-bond donors: 1, H-bond acceptors: 6

Apixaban (CID: 10182969)
  Formula: C25H25N5O4, MW: 459.5 g/mol
  XLogP: 2.2, TPSA: 111 Ų
  H-bond donors: 1, H-bond acceptors: 5
```

### GLP-1 Agonists
```bash
$ python3 get_anticoagulant_chemical_properties.py semaglutide liraglutide

semaglutide (CID: 56843331)
  Formula: C187H291N45O59, MW: 4114 g/mol
  XLogP: -5.8, TPSA: 1650 Ų
  H-bond donors: 57, H-bond acceptors: 63

liraglutide (CID: 16134956)
  Formula: C172H265N43O51, MW: 3751 g/mol
  XLogP: -3.4, TPSA: 1510 Ų
  H-bond donors: 54, H-bond acceptors: 55
```

**Note**: GLP-1 agonists are peptides (MW ~4000 Da) → violate Lipinski's Rule but administered by injection

## Key Features

### 1. Parameterized Design (Works for ANY Drugs)

**Key Innovation**: Unlike most skills, this is **fully parameterized** and works for any drugs:

**Before (Hardcoded)**:
```python
# OLD: Fixed to 3 anticoagulants
compounds = [
    {"name": "Warfarin", "cid": 54678486},
    {"name": "Rivaroxaban", "cid": 9875401},
    {"name": "Apixaban", "cid": 10182969}
]
```

**After (Parameterized)**:
```python
# NEW: Accepts any drug names as input
def get_anticoagulant_chemical_properties(drug_names: Optional[List[str]] = None):
    # Dynamic PubChem search to find CIDs
    for drug_name in drug_names:
        search_result = search_compounds(query=drug_name)
        cid = search_result['details']['PropertyTable']['Properties'][0]['CID']
```

**Benefits**:
- ✅ **Universal**: Works for any specific drugs (anticoagulants, GLP-1s, statins, NSAIDs, etc.)
- ✅ **Flexible**: Analyze 1 drug or 100 drugs with same code
- ✅ **No maintenance**: No hardcoded CIDs to update
- ✅ **Discoverable**: PubChem search handles synonyms and brand names

**Limitation**: Must provide specific drug names, NOT drug classes (PubChem API constraint)

**Use Cases**:
- Compare competitors within same class (semaglutide vs liraglutide)
- Analyze cross-class properties (warfarin vs aspirin)
- Screen large compound libraries for Lipinski compliance
- Quick property lookup for any drug name

### 2. Drug-Likeness Assessment (Lipinski's Rule of 5)

Evaluates oral bioavailability predictors:

**Lipinski's Rule of 5 Criteria** (good oral absorption if ≤1 violation):
- Molecular weight ≤ 500 Da
- LogP ≤ 5 (lipophilicity)
- H-bond donors ≤ 5
- H-bond acceptors ≤ 10

**Compound Analysis**:

| Drug | MW | LogP | HBD | HBA | Violations | Assessment |
|------|----|----|-----|-----|-----------|------------|
| **Warfarin** | 308.3 | 2.7 | 1 | 4 | 0 | ✅ Excellent oral bioavailability |
| **Rivaroxaban** | 435.9 | 2.5 | 1 | 6 | 0 | ✅ Compliant DOAC |
| **Apixaban** | 459.5 | 2.2 | 1 | 5 | 0 | ✅ Optimized for oral delivery |

**Insight**: All three drugs are Lipinski-compliant, confirming their suitability for oral administration. DOACs maintain compliance despite higher complexity (MW ~440-460 vs warfarin 308).

### 3. Blood-Brain Barrier (BBB) Permeability

**TPSA (Topological Polar Surface Area)** predicts CNS penetration:
- **TPSA < 60-70 Ų**: Likely BBB permeable (CNS effects expected)
- **TPSA > 140 Ų**: Likely BBB impermeable (minimal CNS effects)

**Anticoagulant TPSA Analysis**:
- **Warfarin**: 63.6 Ų → **Moderate BBB permeability** (CNS bleeding risk)
- **Rivaroxaban**: 116 Ų → **Low BBB permeability** (safer CNS profile)
- **Apixaban**: 111 Ų → **Low BBB permeability** (safer CNS profile)

**Clinical Relevance**: DOACs' higher TPSA (110-116 Ų) suggests lower intracranial hemorrhage risk vs warfarin (63.6 Ų), confirmed in clinical trials (ARISTOTLE, ROCKET-AF).

### 4. Lipophilicity (XLogP) and Membrane Permeability

**XLogP** (partition coefficient) predicts:
- Membrane permeability
- Plasma protein binding
- Volume of distribution

**Anticoagulant Lipophilicity**:
- **Warfarin**: XLogP 2.7 → Moderate lipophilicity, 99% protein bound
- **Rivaroxaban**: XLogP 2.5 → Similar lipophilicity, 92-95% protein bound
- **Apixaban**: XLogP 2.2 → Slightly less lipophilic, 87% protein bound

**Optimal Range**: XLogP 2-3 balances membrane permeability with aqueous solubility - all three drugs are optimally designed.

### 5. Hydrogen Bonding Characteristics

Hydrogen bonding influences:
- Protein binding affinity
- Receptor selectivity
- Solubility

**Anticoagulant H-Bond Profile**:
- **All three drugs**: 1 donor, 4-6 acceptors
- **Low donor count** → Minimal self-aggregation, good solubility
- **Moderate acceptor count** → Selective target binding without promiscuity

### 6. Generational Comparison: Warfarin vs DOACs

**Chemical Evolution from Warfarin to DOACs**:

| Property | Warfarin (1954) | Rivaroxaban (2011) | Apixaban (2012) |
|----------|----------------|-------------------|----------------|
| **MW** | 308.3 (smaller) | 435.9 | 459.5 |
| **LogP** | 2.7 (most lipophilic) | 2.5 | 2.2 (least lipophilic) |
| **TPSA** | 63.6 (lowest) | 116 (higher) | 111 (higher) |
| **Complexity** | Simple coumarin | Morpholinone + thiophene | Pyrazolopyridinone |
| **Target** | Vitamin K epoxide reductase | Factor Xa (direct) | Factor Xa (direct) |

**Design Insights**:
- **Increased MW**: DOACs are larger (435-460 vs 308 Da) but maintain Lipinski compliance
- **Increased TPSA**: DOACs intentionally designed with higher polarity → lower BBB penetration → better safety
- **Maintained LogP**: All drugs optimized for similar membrane permeability (LogP 2.2-2.7)

## Implementation Details

### Architecture: Parameterized + Dynamic CID Lookup (November 2025 Refactor)

**Major Redesign**: Transformed from hardcoded 3-drug tool to universal drug analyzer

**Flow**:
```
User provides drug names
       ↓
Step 1: PubChem Search (search_compounds)
  - Query: Drug name (e.g., "semaglutide")
  - Returns: {'details': {'PropertyTable': {'Properties': [{'CID': 56843331, ...}]}}}
  - Extract: CID from first result
       ↓
Step 2: Property Retrieval (get_compound_properties)
  - Query: CID + property list
  - Returns: Molecular descriptors
       ↓
Step 3: Structured Output
  - Standardized dict for each drug
```

**Code Architecture**:
```python
def get_anticoagulant_chemical_properties(drug_names: Optional[List[str]] = None):
    """Parameterized function - works for ANY drugs"""

    # Default to anticoagulants if no drugs specified (backward compatible)
    if drug_names is None:
        drug_names = ["Warfarin", "Rivaroxaban", "Apixaban"]

    for drug_name in drug_names:
        # Step 1: Dynamic CID lookup
        search_result = search_compounds(query=drug_name, max_records=1)
        cid = search_result['details']['PropertyTable']['Properties'][0]['CID']

        # Step 2: Get properties
        response = get_compound_properties(cid=str(cid), properties=properties)
        prop_data = response["PropertyTable"]["Properties"][0]

        # Step 3: Store standardized result
        results.append({...})
```

### API Fix History (November 2025)

**Issue 1**: Script returned 0 compounds - incorrect `properties` parameter format

**Root Cause**:
```python
# INCORRECT (original code)
response = get_compound_properties(
    cid=str(compound["cid"]),
    properties=",".join(properties)  # ❌ String format
)
```

**Fix Applied**:
```python
# CORRECT (fixed code)
response = get_compound_properties(
    cid=str(compound["cid"]),
    properties=properties  # ✅ List format
)
```

**Issue 2**: Search result parsing - CID extraction failed

**Fix**: Updated to correct response structure `search_result['details']['PropertyTable']['Properties'][0]['CID']`

### Response Structures

**PubChem Search Response** (`search_compounds`):
```python
{
    'query': 'aspirin',
    'search_type': 'name',
    'total_found': 1,
    'details': {
        'PropertyTable': {
            'Properties': [{
                'CID': 2244,
                'MolecularFormula': 'C9H8O4',
                'MolecularWeight': '180.16',
                ...
            }]
        }
    }
}
```

**PubChem Properties Response** (`get_compound_properties`):
```python
{
    'PropertyTable': {
        'Properties': [{
            'CID': 54678486,
            'MolecularFormula': 'C19H16O4',
            'MolecularWeight': '308.3',
            'ConnectivitySMILES': 'CC(=O)CC(...)O',  # Note: ConnectivitySMILES not CanonicalSMILES
            'InChI': 'InChI=1S/C19H16O4/...',
            'XLogP': 2.7,
            'TPSA': 63.6,
            'HBondDonorCount': 1,
            'HBondAcceptorCount': 4
        }]
    }
}
```

**Parsing Logic**:
```python
prop_data = response["PropertyTable"]["Properties"][0]
molecular_formula = prop_data.get("MolecularFormula")
```

### Error Handling

**Robust search failure handling**:
- Drug not found in PubChem → Warning message, skip to next drug
- Multiple search results → Uses first (highest relevance) result
- Property retrieval failure → Error message, continues with remaining drugs
- Zero results total → Returns empty data list (graceful degradation)

**Output**:
```
Looking up dulaglutide...
  ⚠️  No results found for dulaglutide
```

## Strategic Applications

### 1. Drug Design and Optimization

- **BBB permeability prediction**: TPSA analysis guides CNS safety profiling
- **Bioavailability screening**: Lipinski compliance predicts oral absorption
- **Lead optimization**: Use as reference for novel anticoagulant design
- **SAR studies**: Structural features correlate with safety/efficacy

### 2. Competitive Intelligence

- **Patent landscape**: InChI/SMILES enable freedom-to-operate searches
- **Biosimilar development**: Structural analysis for generic formulation
- **Differentiation opportunities**: Identify chemical space gaps vs competitors
- **Next-generation design**: Learn from DOAC improvements over warfarin

### 3. Formulation Development

- **Solubility prediction**: LogP and H-bonding inform formulation strategy
- **Salt selection**: pKa (derivable from structure) guides salt screening
- **Excipient compatibility**: Polar surface area predicts interactions
- **Bioavailability enhancement**: Target properties for improved formulations

### 4. Clinical Development Planning

- **Drug-drug interaction risk**: LogP and protein binding predict CYP interactions
- **Dose prediction**: MW and lipophilicity inform PK modeling
- **Safety profiling**: BBB permeability (TPSA) guides CNS safety monitoring
- **Patient stratification**: Chemical properties inform PGx biomarker strategies

### 5. Regulatory Strategy

- **INN nomenclature**: SMILES/InChI required for WHO drug naming
- **Patent filing**: Structural identifiers for claims and prior art searches
- **Quality specifications**: Molecular formula/MW for CMC documentation
- **Comparator justification**: Physicochemical similarity for bridging studies

## Related Skills

- **glp1-agonist-properties**: Similar chemical property analysis for metabolic drugs
- **aspirin-properties**: Single-compound chemical analysis pattern
- **kras-inhibitor-scaffold-analysis**: Scaffold-based structural comparison
- **companies-by-moa**: Identify companies developing anticoagulants
- **get_clinical_trials**: Clinical trial landscape for anticoagulants

## Limitations

1. **❌ Drug class searches NOT supported**: PubChem `search_compounds` API only accepts specific compound names, CAS numbers, or formulas - NOT drug classes (e.g., "oral anticoagulants", "SGLT2 inhibitors", "NSAIDs"). This is a PubChem API limitation, not a skill limitation. You must provide specific drug names (e.g., "warfarin", "empagliflozin", "ibuprofen").
2. **PubChem dependency**: Drugs must exist in PubChem database (~110M compounds)
3. **Name matching**: Drug name must match PubChem nomenclature (brand names may fail)
4. **First result only**: Uses top search result (may not be desired compound for ambiguous names)
5. **No stereochemistry**: SMILES are connectivity-based (not stereo-specific)
6. **No metabolites**: Only parent compounds analyzed (no active metabolites)
7. **Predicted properties**: XLogP and TPSA are calculated (not experimental)
8. **No pharmacokinetics**: Chemical properties only (no ADME data)
9. **No bioassay data**: PubChem has bioactivity data not extracted here
10. **No salt forms**: Properties for free base/acid only (not commercial salts)
11. **Rate limits**: Large batch queries (>100 drugs) may hit PubChem API limits

## Data Quality

- **Source**: PubChem (NIH National Library of Medicine) - gold standard chemical database
- **CID validation**: Manually verified CIDs match FDA-approved commercial forms
- **Property calculation**: PubChem algorithms validated against experimental data
- **Completeness**: All 8 requested properties successfully retrieved for all 3 drugs
- **Currency**: Live PubChem query (properties updated as database evolves)

## Verification

✅ **Parameterized design**: Accepts specific drug names as input (list of strings)
✅ **Dynamic CID lookup**: PubChem search working correctly for specific drug names
✅ **Default behavior**: Falls back to anticoagulants if no drugs specified
✅ **Command-line args**: Parses drug names from sys.argv (all args = drug names)
✅ **Error handling**: Gracefully handles drug not found, continues with remaining drugs
✅ **Multiple specific drugs tested**:
  - Default anticoagulants (warfarin, rivaroxaban, apixaban) → 3/3 success
  - GLP-1 agonists (semaglutide, liraglutide) → 2/2 success
  - NSAIDs (aspirin) → 1/1 success
  - Diabetes drugs (metformin, empagliflozin, canagliflozin) → tested successfully
✅ **Drug class searches removed**: Simplified to only handle specific drug names (PubChem API constraint)
✅ **API fix**: Properties parameter passed as list (not comma-separated string)
✅ **Response parsing**: Correctly extracts CID from search results and properties from get_compound_properties
✅ **SMILES key**: Uses ConnectivitySMILES (not CanonicalSMILES)
✅ **Executable**: Standalone with `if __name__` and command-line support
✅ **Schema**: Valid structured output
✅ **Token efficiency**: 99% (minimal PubChem response size ~150 tokens per compound)

## Future Enhancements

Potential improvements for future versions:
1. **Expand drug coverage**: Add edoxaban, dabigatran, fondaparinux, heparins
2. **Metabolite analysis**: Include active metabolites (e.g., dabigatran from prodrug)
3. **Bioassay integration**: Extract PubChem bioactivity data (factor Xa IC50)
4. **3D conformers**: Retrieve 3D structures for docking simulations
5. **Salt form analysis**: Compare free base vs commercial salt properties
6. **Experimental data**: Augment with measured LogP, pKa, solubility
7. **Safety data**: Integrate PubChem GHS classifications
8. **Patent linkage**: Connect structures to patent numbers and expiry dates
